Detalhe da pesquisa
1.
Comparison of nodal staging between CT, MRI, and [18F]-FDG PET/MRI in patients with newly diagnosed breast cancer.
Eur J Nucl Med Mol Imaging
; 49(3): 992-1001, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34476552
2.
Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression.
Breast Cancer Res
; 22(1): 75, 2020 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32660617
3.
Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients.
BMC Cancer
; 19(1): 1101, 2019 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31718606
4.
Diagnostic leukapheresis for CTC analysis in breast cancer patients: CTC frequency, clinical experiences and recommendations for standardized reporting.
Cytometry A
; 93(12): 1213-1219, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30551262
5.
Correction to: Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression.
Breast Cancer Res
; 23(1): 13, 2021 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33509243
6.
Discussion of ABC7 Consensus and German Recommendations.
Geburtshilfe Frauenheilkd
; 84(5): 431-442, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38817599
7.
ABC7 Consensus: Assessment by a German Group of Experts.
Breast Care (Basel)
; 19(2): 116-128, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38638343
8.
Acid ceramidase (AC)--a key enzyme of sphingolipid metabolism--correlates with better prognosis in epithelial ovarian cancer.
Int J Gynecol Pathol
; 32(3): 249-57, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23518908
9.
Is the (Neo)adjuvant Therapy of Patients with Primary HER2-positive Breast Cancer Cost-Covering?: Process Cost Analysis of Neoadjuvant and Post-Neoadjuvant Systemic Therapy of Patients with Primary HER2-positive Breast Cancer.
Geburtshilfe Frauenheilkd
; 83(3): 321-332, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36908284
10.
Whole Exome Analysis to Select Targeted Therapies for Patients with Metastatic Breast Cancer - A Feasibility Study.
Geburtshilfe Frauenheilkd
; 83(9): 1138-1147, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37706056
11.
Conventional Imaging, MRI and 18F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast Cancer.
Cancers (Basel)
; 15(14)2023 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37509307
12.
Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on 18F-FDG PET/MRI and Machine Learning.
J Nucl Med
; 64(2): 304-311, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36137756
13.
Controversies concerning the use of neoadjuvant systemic therapy for primary breast cancer.
World J Surg
; 36(7): 1480-5, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22278605
14.
A Role of PET/MR in Breast Cancer?
Semin Nucl Med
; 52(5): 611-618, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35260243
15.
Early Outcome, Cosmetic Result and Tolerability of an IOERT-Boost Prior to Adjuvant Whole-Breast Irradiation.
Cancers (Basel)
; 14(15)2022 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35892894
16.
Invasive Breast Carcinoma with Neuroendocrine Differentiation: A Single-Center Analysis of Clinical Features and Prognosis.
Geburtshilfe Frauenheilkd
; 82(1): 68-84, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35027862
17.
Post-Neoadjuvant Treatment Strategies in Breast Cancer.
Cancers (Basel)
; 14(5)2022 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35267554
18.
Evaluation of Intraoperative Frozen Section Analysis with Final Histopathology Results for Sentinel Lymph Node Biopsy: Z0011 Criteria Eligible Versus Ineligible Breast Cancer Patients.
Geburtshilfe Frauenheilkd
; 82(6): 610-618, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35903717
19.
Predictive Factors of Long-Term Survival after Neoadjuvant Radiotherapy and Chemotherapy in High-Risk Breast Cancer.
Cancers (Basel)
; 14(16)2022 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36011025
20.
Multiparametric 18F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
Cancers (Basel)
; 14(7)2022 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35406499